267 related articles for article (PubMed ID: 19378382)
1. Akathisia and second-generation antipsychotic drugs.
Kumar R; Sachdev PS
Curr Opin Psychiatry; 2009 May; 22(3):293-99. PubMed ID: 19378382
[TBL] [Abstract][Full Text] [Related]
2. Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Chen J; Gao K; Kemp DE
Curr Opin Psychiatry; 2011 Jan; 24(1):10-7. PubMed ID: 21088586
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
5. A typical mood stabilizers: a "typical role for atypical antipsychotics.
Malhi GS; Berk M; Bourin M; Ivanovski B; Dodd S; Lagopoulos J; Mitchell PB
Acta Psychiatr Scand Suppl; 2005; (426):29-38. PubMed ID: 16104066
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
[TBL] [Abstract][Full Text] [Related]
7. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
Wang PS; Schneeweiss S; Setoguchi S; Patrick A; Avorn J; Mogun H; Choudhry NK; Brookhart MA
J Clin Psychopharmacol; 2007 Dec; 27(6):707-10. PubMed ID: 18004143
[No Abstract] [Full Text] [Related]
8. Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Dubois D
Curr Opin Pediatr; 2005 Apr; 17(2):227-33. PubMed ID: 15800418
[TBL] [Abstract][Full Text] [Related]
9. Switching antipsychotic medications: not enough, too often, or just right?
Weiden PJ
Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
[No Abstract] [Full Text] [Related]
10. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
11. The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Citrome L; Volavka J
Postgrad Med; 2004 Oct; 116(4):49-51, 55-9, 63. PubMed ID: 15510593
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
McDougle CJ; Stigler KA; Erickson CA; Posey DJ
J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics for the treatment of disruptive behavior.
Lohr WD; Honaker J
Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
[No Abstract] [Full Text] [Related]
14. Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Moons T; Claes S; Martens GJ; Peuskens J; Van Loo KM; Van Schijndel JE; De Hert M; van Winkel R
Schizophr Res; 2011 Feb; 125(2-3):187-93. PubMed ID: 21050724
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia in a patient treated with quetiapine.
Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
[TBL] [Abstract][Full Text] [Related]
16. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
[TBL] [Abstract][Full Text] [Related]
17. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Hilger E; Kasper S
Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.
Melnik T; Soares BG; Puga ME; Atallah AN
Sao Paulo Med J; 2010 May; 128(3):141-66. PubMed ID: 20963366
[TBL] [Abstract][Full Text] [Related]
20. Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
Moteshafi H; Stip E
Expert Opin Drug Saf; 2012 Sep; 11(5):713-32. PubMed ID: 22913713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
